85. 特発性間質性肺炎 Idiopathic interstitial pneumonia Clinical trials / Disease details


臨床試験数 : 627 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05497284
(ClinicalTrials.gov)
November 10, 20225/8/2022To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPFA Participant- and Investigator-blinded, Randomized, Placebo-controlled, Multicenter, Platform Study to Investigate Efficacy, Safety, and Tolerability of Various Single Treatments in Participants With Idiopathic Pulmonary FibrosisIdiopathic Pulmonary FibrosisDrug: LTP001;Drug: Placebo;Drug: Standard of Care (SoC)Novartis PharmaceuticalsNULLRecruiting40 YearsN/AAll94Phase 2United States;Argentina;Australia
2NCT03287414
(ClinicalTrials.gov)
December 20, 201712/9/2017Study of Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of VAY736 in Patients With Idiopathic Pulmonary FibrosisA Subject-, Investigator-, and Sponsor-blinded, Randomized, Placebo-controlled, Multicenter Study to Investigate Efficacy, Safety, and Tolerability of VAY736 in Patients With Idiopathic Pulmonary FibrosisIdiopathic Pulmonary FibrosisDrug: VAY736;Drug: Placebo;Drug: Standard of Care (SoC)Novartis PharmaceuticalsNULLCompleted40 Years80 YearsAll30Phase 2United States;Canada;Germany;Ireland;Italy;United Kingdom;France